Hedge funds edge towards USD4 trillion milestone as volatility surges
Total hedge fund industry assets have swelled to almost USD4 trillion globally, a rise of nearly USD370 billion since the start of this year, according to new capital flows data.
Total hedge fund industry assets have swelled to almost USD4 trillion globally, a rise of nearly USD370 billion since the start of this year, according to new capital flows data.
US investment consultant, Meketa Investment Group, is looking for hedge fund risk mitigation and diversification strategies, as it looks to de-risk client exposure to directional equities.
Massar Capital Management has launched a new discretionary macro hedge fund strategy which aims to capitalise on directional trading opportunities across a broad set of global markets.
Sir Christopher Hohn’s TCI Fund Management has set out a strategic plan to overhaul Canadian National Railway which it says would put the Montreal-headquartered freight railway company “back on track.” The London-based activist hedge fund this week outlined sweeping proposals
Optiver, a global market maker, has launched its corporate strategic investment initiative, Optiver Principal Strategic Investments (PSI). For more than 35 years, Optiver has been committed to improving global financial markets at every stage, for all parties involved. Through Optiver
Hedge funds’ overall momentum in 2021 has been halted, with managers across a range of strategy classes left counting the cost of September’s bumpy equity and credit market reversal, new industry data published this week shows.
Man Group’s funds under management reached a new high of USD139.5 billion during the third quarter, fueled by positive inflows and strong investment performance, with its hedge fund and alternative strategies driving growth.
Co-founded by former Lynx Asset Management portfolio manager Martin Sandquist, Stockholm-based investment management firm Antiloop brings together discretionary and quantitative trading in a multi-strategy fund that spans commodities, equities, global macro and emerging markets.
The development of molnupiravir, a “potent” oral anti-viral Covid-19 treatment, could help boost flagging consumer stocks reliant on the global economic reopening, as healthcare-focused hedge funds look to rebound following recent losses.
With traditional equity and credit returns set for a squeeze, and ESG, Covid-19 and remote working upending the hedge fund industry from both an investment and operations perspective, managers face both considerable challenges and sizable opportunities up ahead, speakers at